NanoViricides launches at-the-market offering of up to $4.0M at $1.51/share

Filed July 17, 2026 · ~1 min read

Key Changes

• high

  NanoViricides may sell up to $4,018,069 of common stock in an at-the-market offering through D. Boral Capital, with a 2% commission.

  The Offering verify on EDGAR →
• high

  New investors face immediate dilution of $0.99 per share, as the offering price of $1.51 exceeds the as-adjusted net tangible book value of $0.52 per share.

  Dilution verify on EDGAR →
• high

  The company's auditor, EisnerAmper LLP, has issued a going-concern qualification, citing substantial doubt about NanoViricides' ability to continue as a going concern.

  Experts view on EDGAR →